RebeccaLOlinMD
Oncology • San Francisco, CAHematologic Oncology
Assistant Professor, Medicine, UCSF School of Medicine
Dr. Olin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
Box 0324
San Francisco, CA 94143Phone+1 415-353-2063
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2006 - 2009- University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
Perelman School of Medicine at the University of PennsylvaniaClass of 2003
Certifications & Licensure
CA State Medical License 2009 - 2026
PA State Medical License 2003 - 2010- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen Start of enrollment: 2009 Nov 01
- Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) Start of enrollment: 2011 Sep 01
- Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 198 citationsIncreasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, Marcelo C. Pasquini, Michael Martens, Ruta Brazauskas, Xiaochun Zhu
Blood. 2017-08-31 - 722 citationsGilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AMLAlexander E. Perl, Giovanni Martinelli, Jorge E. Cortes, Andreas Neubauer, Ellin Berman
The New England Journal of Medicine. 2019-10-30 - 280 citationsAcute myeloid leukemia, version 3.2019Martin S. Tallman, Eunice S. Wang, Jessica K. Altman, Frederick R. Appelbaum, Vijaya Raj Bhatt
Journal of the National Comprehensive Cancer Network. 2019-01-01
Abstracts/Posters
- Incidence of Serious Adverse Events, Pneumonitis, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphom...Rebecca L. Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndr...Rebecca Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative NeoplasmsRebecca L. Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Friday Scientific Workshop on Hematology and Aging: From Bleeding Disorders to Malignant Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Aging and Hematologic Disorders: Exploring the Evidence61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
